|
|
Article: Company reports third quarter earnings of $0.50 per share on 14% revenue growth.
- Article from:
- Biotech Week
- Article date:
- November 12, 2003
CopyrightCOPYRIGHT 2003 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
2003 NOV 12 - (NewsRx.com & NewsRx.net) -- Millipore Corp. (MIL) announced its third-quarter sales were $200 million, up 14% from the same period last year.
Sales growth in local currencies was 9%. Third-quarter earnings from continuing operations were $0.50 per share, which includes a $0.01-per-share gain on the sale of real estate.
Fran Lunger, Millipore's chairman, CEO, and president, said: "Our third- quarter revenue growth was a combination of 16% local-currency growth in biotechnology and 5% local currency growth in both life sciences and other bioscience. The strong performance in biotechnology reflects an increase in demand ...